News and Announcements

Johnson & Johnson expands project that aims to predict, prevent diseases

March 23rd, 2016 in Funding, Press Release.

March 22, 2016 | Written By: Tribune news services | Source: ChicagoTribune Johnson & Johnson has ramped up its ambitious project to learn how to predict who will develop particular diseases and find therapies to prevent or stop the disease early, when it's most treatable. Since the health care giant announced its... More

How RNA Editing May Promote Tumor Growth

March 21st, 2016 in Publications.

Thursday, March 17 2016 | Source: BUSM A new study provides insight on the potential role played by RNA (ribonucleic acid) editing in cancer. The findings, which appear online in the journal Scientific Reports, may further our understanding of an emerging mechanism implicated in tumor initiation and progression, and may thus lead to... More

Six Junior Faculty Receive Career Development Awards

September 27th, 2016 in Research Highlight.

Written by: Amy Laskowski | Source: Bostonia Jerry Chen received quite a present just three months after arriving at BU. Chen, a College of Arts & Sciences assistant professor of biology, is the winner of this year’s Stuart and Elizabeth Pratt Career Development Professorship, which highlights excellence within CAS. A neuroscientist who uses... More

New Consortium to Study Environmental Causes of Breast Cancer

August 17th, 2016 in Research Highlight.

Written by: Rich Barlow | Source: BU Research Cancer researcher David Sherr is gunning for a disease that has upended his life. His wife died from multiple myeloma 15 years ago. So when the Art beCAUSE Breast Cancer Foundation, a nonprofit supporting research into the environmental causes of breast cancer, approached him for ideas to... More

Stopping Lung Cancer Before It Gets Going

March 22nd, 2016 in Funding, Research Highlight.

March 7, 2016 | Written By: Upal Basu Roy, MPH, PhD | Source: LUNGevity “The LUNGevity award provided me the resources to study premalignant lung cells—a stage in which normal lung cells have changed, but not yet completely into cancer cells. This is an extremely important area of cancer research for... More

New test could sharply reduce risky, costly lung cancer biopsies

May 18th, 2015 in Press Release, Publications.

Press Release: May 18, 2015 | Written by Lenny Bernstein - The Washington Post When a suspicious lesion shows up in the lungs on a CT scan, the first thing your doctor wants to know is whether it's cancerous. A specialist will pass a long, thin bronchoscope into your airway in the hope of... More

Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier

April 30th, 2015 in Press Release.

Press: April 16, 2015 | Veracyte South San Francisco, Calif. --- April 16, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The... More

Behind the Vapor – Chasing the facts behind e-cigarette health risks

October 22nd, 2014 in Press Release.

Press: October 20, 2014; written by Sara Rimer | BU Research  With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact... More

Researchers will study relation of environment to breast cancer

October 17th, 2014 in Press Release.

Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made... More

Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test

September 9th, 2014 in Press Release.

Press release: September 4th 2014  SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ -- Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte... More